The bioavailability of vitamin D3, a model hydrophobic nutraceutical, in casein micelles, as model protein nanoparticles: Human clinical trial results

The use of protective protein-based nanovehicles to deliver hydrophobic nutraceuticals raises important questions regarding their consequent bioavailability compared to that inside fat, or in its presence. To answer that, vitamin-D3 was chosen as a model lipophilic-bioactive, re-assembled casein mic...

Full description

Bibliographic Details
Main Authors: Yifat Cohen, Sofia Ish-Shalom, Elena Segal, Olga Nudelman, Avi Shpigelman, Yoav D. Livney
Format: Article
Language:English
Published: Elsevier 2017-03-01
Series:Journal of Functional Foods
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1756464617300191
_version_ 1818871374022705152
author Yifat Cohen
Sofia Ish-Shalom
Elena Segal
Olga Nudelman
Avi Shpigelman
Yoav D. Livney
author_facet Yifat Cohen
Sofia Ish-Shalom
Elena Segal
Olga Nudelman
Avi Shpigelman
Yoav D. Livney
author_sort Yifat Cohen
collection DOAJ
description The use of protective protein-based nanovehicles to deliver hydrophobic nutraceuticals raises important questions regarding their consequent bioavailability compared to that inside fat, or in its presence. To answer that, vitamin-D3 was chosen as a model lipophilic-bioactive, re-assembled casein micelles (rCM) as a protein-based nanovehicle and 0% fat yoghurt as a model nonfat food. We performed a single-high-dose-ingestion clinical trial with 94 healthy human volunteers, each receiving 150 g yoghurt containing 50,000 IU of vitamin-D3. Vitamin-D3 was either in rCM in the absence or presence of fat, or dissolved in milk fat. Un-enriched nonfat yoghurt was the negative control. The bioavailability of vitamin-D3 was determined by measuring its status-indicator: serum 25-hydroxyvitamin D level. The bioavailability of vitamin-D3 within the protein nanoparticles in the absence of fat was found to be insignificantly different from its bioavailability within fat, suggesting that the bioavailability of lipophilic bioactives in protein nanovehicles is not lower than in fat.
first_indexed 2024-12-19T12:21:54Z
format Article
id doaj.art-c871a39305ef49d1925afe9319e0359b
institution Directory Open Access Journal
issn 1756-4646
language English
last_indexed 2024-12-19T12:21:54Z
publishDate 2017-03-01
publisher Elsevier
record_format Article
series Journal of Functional Foods
spelling doaj.art-c871a39305ef49d1925afe9319e0359b2022-12-21T20:21:45ZengElsevierJournal of Functional Foods1756-46462017-03-0130321325The bioavailability of vitamin D3, a model hydrophobic nutraceutical, in casein micelles, as model protein nanoparticles: Human clinical trial resultsYifat Cohen0Sofia Ish-Shalom1Elena Segal2Olga Nudelman3Avi Shpigelman4Yoav D. Livney5Department of Biotechnology & Food Engineering, Technion- Israel Institute of Technology, Haifa 3200000, IsraelBone and Mineral Metabolism Unit, Rambam Health Care Campus, Haifa 3525408, Israel; Faculty of Medicine, Technion- Israel Institute of Technology, Haifa 3525406, IsraelBone and Mineral Metabolism Unit, Rambam Health Care Campus, Haifa 3525408, Israel; Faculty of Medicine, Technion- Israel Institute of Technology, Haifa 3525406, IsraelBone and Mineral Metabolism Unit, Rambam Health Care Campus, Haifa 3525408, Israel; Faculty of Medicine, Technion- Israel Institute of Technology, Haifa 3525406, IsraelDepartment of Biotechnology & Food Engineering, Technion- Israel Institute of Technology, Haifa 3200000, IsraelDepartment of Biotechnology & Food Engineering, Technion- Israel Institute of Technology, Haifa 3200000, Israel; Russell Berrie Nanotechnology Institute, Technion- Israel Institute of Technology, Haifa 3200000, Israel; Corresponding author at: Department of Biotechnology & Food Engineering, Technion- Israel Institute of Technology, Haifa 3200000, Israel.The use of protective protein-based nanovehicles to deliver hydrophobic nutraceuticals raises important questions regarding their consequent bioavailability compared to that inside fat, or in its presence. To answer that, vitamin-D3 was chosen as a model lipophilic-bioactive, re-assembled casein micelles (rCM) as a protein-based nanovehicle and 0% fat yoghurt as a model nonfat food. We performed a single-high-dose-ingestion clinical trial with 94 healthy human volunteers, each receiving 150 g yoghurt containing 50,000 IU of vitamin-D3. Vitamin-D3 was either in rCM in the absence or presence of fat, or dissolved in milk fat. Un-enriched nonfat yoghurt was the negative control. The bioavailability of vitamin-D3 was determined by measuring its status-indicator: serum 25-hydroxyvitamin D level. The bioavailability of vitamin-D3 within the protein nanoparticles in the absence of fat was found to be insignificantly different from its bioavailability within fat, suggesting that the bioavailability of lipophilic bioactives in protein nanovehicles is not lower than in fat.http://www.sciencedirect.com/science/article/pii/S1756464617300191Vitamin DCasein micellesBioavailabilityClinical studyProtein nanoparticles
spellingShingle Yifat Cohen
Sofia Ish-Shalom
Elena Segal
Olga Nudelman
Avi Shpigelman
Yoav D. Livney
The bioavailability of vitamin D3, a model hydrophobic nutraceutical, in casein micelles, as model protein nanoparticles: Human clinical trial results
Journal of Functional Foods
Vitamin D
Casein micelles
Bioavailability
Clinical study
Protein nanoparticles
title The bioavailability of vitamin D3, a model hydrophobic nutraceutical, in casein micelles, as model protein nanoparticles: Human clinical trial results
title_full The bioavailability of vitamin D3, a model hydrophobic nutraceutical, in casein micelles, as model protein nanoparticles: Human clinical trial results
title_fullStr The bioavailability of vitamin D3, a model hydrophobic nutraceutical, in casein micelles, as model protein nanoparticles: Human clinical trial results
title_full_unstemmed The bioavailability of vitamin D3, a model hydrophobic nutraceutical, in casein micelles, as model protein nanoparticles: Human clinical trial results
title_short The bioavailability of vitamin D3, a model hydrophobic nutraceutical, in casein micelles, as model protein nanoparticles: Human clinical trial results
title_sort bioavailability of vitamin d3 a model hydrophobic nutraceutical in casein micelles as model protein nanoparticles human clinical trial results
topic Vitamin D
Casein micelles
Bioavailability
Clinical study
Protein nanoparticles
url http://www.sciencedirect.com/science/article/pii/S1756464617300191
work_keys_str_mv AT yifatcohen thebioavailabilityofvitamind3amodelhydrophobicnutraceuticalincaseinmicellesasmodelproteinnanoparticleshumanclinicaltrialresults
AT sofiaishshalom thebioavailabilityofvitamind3amodelhydrophobicnutraceuticalincaseinmicellesasmodelproteinnanoparticleshumanclinicaltrialresults
AT elenasegal thebioavailabilityofvitamind3amodelhydrophobicnutraceuticalincaseinmicellesasmodelproteinnanoparticleshumanclinicaltrialresults
AT olganudelman thebioavailabilityofvitamind3amodelhydrophobicnutraceuticalincaseinmicellesasmodelproteinnanoparticleshumanclinicaltrialresults
AT avishpigelman thebioavailabilityofvitamind3amodelhydrophobicnutraceuticalincaseinmicellesasmodelproteinnanoparticleshumanclinicaltrialresults
AT yoavdlivney thebioavailabilityofvitamind3amodelhydrophobicnutraceuticalincaseinmicellesasmodelproteinnanoparticleshumanclinicaltrialresults
AT yifatcohen bioavailabilityofvitamind3amodelhydrophobicnutraceuticalincaseinmicellesasmodelproteinnanoparticleshumanclinicaltrialresults
AT sofiaishshalom bioavailabilityofvitamind3amodelhydrophobicnutraceuticalincaseinmicellesasmodelproteinnanoparticleshumanclinicaltrialresults
AT elenasegal bioavailabilityofvitamind3amodelhydrophobicnutraceuticalincaseinmicellesasmodelproteinnanoparticleshumanclinicaltrialresults
AT olganudelman bioavailabilityofvitamind3amodelhydrophobicnutraceuticalincaseinmicellesasmodelproteinnanoparticleshumanclinicaltrialresults
AT avishpigelman bioavailabilityofvitamind3amodelhydrophobicnutraceuticalincaseinmicellesasmodelproteinnanoparticleshumanclinicaltrialresults
AT yoavdlivney bioavailabilityofvitamind3amodelhydrophobicnutraceuticalincaseinmicellesasmodelproteinnanoparticleshumanclinicaltrialresults